The loss of cardiac pump function accounts for a significant increase in both mortality and morbidity in Western society, where there is currently a one in four lifetime risk, and costs associated with acute and long-term hospital treatments are accelerating. The significance of cardiac disease has motivated the application of state-of-the-art clinical imaging techniques and functional signal analysis to aid diagnosis and clinical planning. Measurements of cardiac function currently provide high-resolution datasets for characterizing cardiac patients. However, the clinical practice of using population-based metrics derived from separate image or signal-based datasets often indicates contradictory treatments plans owing to inter-individual variability in pathophysiology. To address this issue, the goal of our work, demonstrated in this study through four specific clinical applications, is to integrate multiple types of functional data into a consistent framework using multi-scale computational modelling.
INTRODUCTION
Cardiovascular disease (CVD) is a highly significant contributor to loss of quality and quantity of life within Europe, where each year CVD causes over 4.35 million deaths, including nearly half of all nonaccidental deaths [1] . It is most commonly a consequence of diseases such as coronary artery disease (CAD), congestive heart failure (HF) and cardiac arrhythmias. Thus, the early detection and prediction of the progression of CVD are key requirements towards improved treatment, and reduction in mortality and morbidity.
The diversity and quantity of currently available imaging data, including measurements of cardiac wall motion [2] , chamber flow patterns [3] , coronary perfusion *Author for correspondence (nicoas.smith@kcl.ac.uk).
One contribution of 17 to a Theme Issue 'The virtual physiological human'. [4] and electrical mapping [5] , present a significant opportunity to improve clinical care of CVD. Similarly, functional measurement of haemodynamic coronary signals results in improved clinical outcome [6] . However, the clinical practice of using population-based metrics derived from separate image sets often indicates contradictory treatment plans owing to inter-subject variability in pathophysiology. Thus, despite advances in imaging and functional measurements, determining optimal treatment strategies for CVD patients remains problematic. To exploit the full value of these technologies, and the combined information content they produce, requires the ability to integrate multiple types of anatomical and functional data into a consistent framework.
An exciting and highly promising strategy for contributing to this integration is through the personalization of bio-physically based mathematical models [7] . The development of such models presents the ability to capture the complex and multi-factorial cause and effect relationships that link underlying pathophysiological mechanisms. This in turn provides the capacity to derive indicators that are not directly observable but play a key mechanistic role in the disease process (for example, tissue stress and measures of pump efficiency to assist treatment decisions). Across international efforts to develop these types of models such as the virtual physiological human (VPH) integrated modelling of the heart is arguably one of the most advanced current examples. As such, it represents an excellent organ system with which to demonstrate the translation of models to clinical application. Specifically, detailed anatomical finite-element (FE)-based models of the heart now accurately represent both cardiac anatomy and detailed microstructure. These mathematical descriptions serve as spatial frameworks for embedding functional cellular models of electrical activation, and the resultant tension generation that produces cardiac contraction. These cell and organ components have been combined through the application of continuum equations to simulate whole-organ cardiac electro-mechanics, perfusion and ventricular fluid dynamics.
However, despite these advances, there remains a significant translational barrier to applying and customizing models for human clinical application. This is because the vast majority of cardiac models are currently developed and validated using data collected from invasive measurements in animal populations under controlled conditions. These models are useful for the demonstration of proof of concept function, development of mechanistic concepts and interpretation of specific animal data. However, there are inherent limitations to such model developments specifically with respect to mimicking disease. Moreover, the relevance of insights gained from such animal models to human health remains difficult to determine [8] .
The current challenge is thus to parameterize and personalize these frameworks for humans using the extensive but only minimally invasive clinical measurements. It is this goal of integration and application in patient-specific contexts that is the focus of our 4 year project called euHeart and funded by the European Commission as part of the VPH initiative calls. 1 The technical work within euHeart is focused on developing the necessary tools to enable clinical applications. This tool development includes the establishment of a library of models of the heart across the euHeart consortium (figure 1) made available via euHeartDB, a web-enabled database [9] . The database implements a dynamic sharing methodology by managing data access and by tracing all applications. In addition to this, euHeartDB establishes a knowledge link with the Physiome Model Repository by linking geometries to CellML models 2 and uses the exFormat-a preliminary version of the interoperable FieldML data format. 3 To enable robust and effective personalization strategies, atlas-based image segmentation techniques [10] are tailored to the specific needs of biophysical simulations. In addition, functional parameter estimation techniques are applied to enable the description of cardiac normal and pathological conditions for the major manifestations of CVD. Most of the clinical applications designed within euHeart are prototyped within the GIMIAS 4 [11] application framework environment, which has enabled the integration of tools across different institutions and the implementation of prototypes shared among the participating groups or currently under testing in our clinical sites.
This library of models and tools is currently being integrated into clinical applications to validate the descriptive capabilities of the approach and to demonstrate the plausibility of improving clinical outcomes, when compared with current best practices, for diagnosis, interventional planning and device or treatment optimization. Specifically, models for HF and electrical rhythm disturbances incorporate the description of ion channel kinetics into the organ-level solution of reaction -diffusion equations for computing the activation sequences in ventricular and atrial tissue. These applications also couple the mechanisms for myofilament force generation at the subcellular level to the fluid-mechanical properties of the chamber and heart wall to capture contractile dynamics. Work on CAD incorporates anatomy, perfusion coupled to whole-heart coronary flow. Mechanical contraction and coronary perfusion are also being linked to the constitutive properties of aortic wall tissue for coupling heart function to the pressure-flow behaviour of the circulation [12] .
The focus of this article is on the clinical applications within which these tools are now being tested. Specifically, these applications are customizing cardiac resynchronization, coronary revascularization and atrial ablation therapies and device implantation, including left ventricular assist device (LVAD) implantation and valve replacement. The data, modelling methodology and results in each of these areas are summarized in the sections below.
CARDIAC RESYNCHRONIZATION THERAPY
One of the targeted clinical applications in euHeart is cardiac resynchronization therapy (CRT), which can relieve HF symptoms by reducing heart dyssynchrony through the implantation of a pacemaker. However, the negative or non-response to CRT rises to 30 per cent [13] owing to challenges in patient selection and pacemaker configurations. This context is a significant issue and focus within the clinical community. The recent update of the official guidelines for CRT from the European Society of Cardiology now includes a number of additional patient groups that were previously omitted [14] . Several research groups are also investigating the testing of new pacing configurations (number and position of leads) in experimental models under fully controlled conditions [15] as well as the different parameters that are related to response to CRT [16] . The hypothesis leading research work on CRT within euHeart is that using patient-specific cardiac models combining the anatomical and functional pre-operative data collected has the potential to provide new insights into the disease and therapy. The generation of these patient-specific models requires a tight, coordinated and collaborative effort between multi-disciplinary teams. Performing cardiac electromechanical simulations requires building a computer model that can represent the subject's heart morphology with sufficient accuracy. Depending on the amount of clinical data available from the patient, cardiac models can be further personalized to a given pathology or therapy such as CRT. Furthermore, the validation of these computational models needs the extraction of information from images and signals so that they can be compared with simulation results. Patient-specific geometry, tissue properties such as local elasticity or local conductivity, deformation/motion information and details on the microstructure are all desirable to ensure the computational models are as realistic as possible. The main components of the workflow for the generation of the personalized computational models required for the CRT planning platform to be developed in the euHeart project are described in the following. Most of these components are already integrated into a common software framework, GIMIAS [11] , which is a workflow-oriented framework extensible through plug-ins, which has been designed for the prototyping of clinical applications requiring streamlined workflows intensively relying on methods of computational imaging and computational physiology.
To support the model development process, new acquisition protocols of cardiac magnetic resonance (MR) have been developed [17] that create threedimensional whole-heart images allowing automatic or semi-automatic cardiac chamber and coronary sinus segmentation, thus streamlining the clinical workflow. From these data, the cardiac geometry is extracted using automatic and semi-automatic segmentation techniques based on atlases computed from population data [18] or statistical shape models that can be applied to whole-heart computed tomography (CT) or MR images [19] . In addition, the user has manual correction tools if the segmentation is not accurate enough. Functional information such as tissue viability, which is crucial for interventional planning, can also be extracted from late-enhancement magnetic resonance imaging (MRI) [20] . Finally, the coronary venous tree is extracted from vascular segmentation techniques [21] since it will constrain the lead placement, thus providing more realistic device settings in the simulations. The structures segmented in the previous phase (four chambers, scar, coronary tree) from MRI are easily fused into the reference space defined from the three-dimensional whole-heart image, as illustrated in figure 2 . In addition, this cardiovascular geometrical information can be overlaid with the X-ray images during the CRT intervention with the pipeline developed at King's College London [17] , making the use of the developed tools in clinical routine possible.
Building on this anatomical framework, a quantitative analysis of the motion/deformation of the heart gives dyssynchrony information, which is particularly relevant for CRT given the aims of restoring synchronous activation of the heart. Towards this goal, threedimensional echocardiographic images were analysed [22] , showing significant differences in strain curves before and after CRT. In addition, algorithms for the quantitative estimation of septal flash [23] , a marker of dyssynchrony that has demonstrated a strong relation with a positive response of CRT, based on computing the distance of a CRT candidate to an atlas of deformation normality, have been developed and tested on a large cohort of patients [24] . Finally, this septal flash pattern was also identified from intracardiac electrical mapping data [25] , allowing a simple integration of electrical data and motion information.
Using the previous segmentations as geometrical boundary conditions for the models, the FE volumetric meshes required for the simulations were built. Depending on the physiological models used, the nature of these FE meshes and associated boundary conditions will be different, mainly with respect to type and number of elements used. Within the CRT planning platform, it is possible to generate high-resolution tetrahedral meshes from patient-specific segmentations for detailed electrophysiological models. Complementing these tetrahedral meshes, warping techniques have been developed [26] in order to generate high-order patientspecific hexahedral meshes, suitable for mechanical simulations. Finally, these volumetric meshes are further augmented by synthetically adding substructural information relevant for CRT, such as myocardial fibre orientation or the Purkinje system [27] , which are boundary conditions significantly changing the outcome of the simulations.
Using these spatial representations, mechanical and electrophysiological cellular models with different levels of complexity (available in the cellML repository) are coupled to tissue activation models and finite deformation mechanics within continuum-based simulation codes optimized for high-performance parallel implementation. Simple electrophysiological models based on Eikonal equations, phenomenological models and more detailed biophysical models are available for the simulation of electrical activation. At the time being, these electrophysiological models are weakly coupled to a nonlinear finite strain elasticity framework for the mechanical simulations. A key step is the personalization of conductivity and stiffness parameters as well as personalizing appropriate boundary conditions, since these variables cannot be measured in vivo.
From the clinical point of view, realistic and personalized physiological models allow in silico tests of different device settings (number and position of leads, chamber delays), which are currently selected suboptimally, as indicated by a lack of consensus in the clinical community. Most of the code has been implemented using open-source platforms such as OpenCMISS 5 and Chaste, 6 which in turn enables collaboration between different research groups. An example of an electrophysiological simulation run with Chaste on a patient-specific geometry extracted from the previous steps is shown in figure 3 , with two different pacing configurations. Furthermore, a simple mechanical simulation run with OpenCMISS on the same patient geometry is also illustrated in the figure.
Finally, once electromechanical simulations are obtained, they are post-processed and compared with information and other indices extracted from imaging and signal data, such as deformation fields from echo images, contact or non-contact mapping data or pressure information. This information allows the combination of different parameters derived from imaging, simulation and other patient-specific data [demographics, electrocardiogram (ECG)-derived parameters, etc.] using machine-learning techniques to classify patients in classes with more or less likelihood for a positive response of CRT. Nevertheless, it needs to be pointed out that current models require substantial improvements before being confidently translated into clinical routine. For instance, electrophysiological, mechanics and fluid models are not strongly coupled yet, thus preventing a complete understanding of the different multi-physics phenomena and their interaction in CRT. Furthermore, these models need to be validated in large cohorts of clinical data; thus, computational improvements are still to be done to streamline the model construction workflow and the generation of patient-specific simulations.
RADIOFREQUENCY ABLATION
Another major component of the increasing rate of CVDs is the rise in cardiac arrhythmias caused by structural disorders of the heart such as myocardial scarring following myocardial infarction, which in turn produces life-threatening arrhythmias such as ventricular tachycardia (VT). Additionally, the prevalence of atrial fibrillation (AF), which is more and more recognized as having a major impact on the patient's quality of life and prognosis, is related to age and roughly doubles with each advancing decade, from 0.5 per cent at age 50-59 years to almost 9 per cent at age 80-90 years.
The clinical understanding and treatment of these patients is complicated and includes a wide range of therapies, going from pharmaceutical to devices (pacemakers and implantable defibrillators) and interventions [surgical or radiofrequency ablation (RFA)]. In a subgroup of patients with chronic and debilitating arrhythmias (such as AF), the use of RFA has shown to be an effective cure. However, RFA is expensive (more than E5000), minimal-invasive and involves a significant radiation exposure for the patient. Additionally, in many cases, the procedure has to be repeated a number of times, with some patients receiving little long-term benefits. With well over 4.5 million patients with AF in Europe, RFA is also having a major impact on rising healthcare costs. Similarly, VT is now commonly being treated with the insertion of intracardiac defibrillators. Thus, while as already discussed RFA is expensive, in this context it has the potential of being a better and cheaper alternative therapy here.
Biophysical models of the cardiac electrophysiology can provide a better understanding of the mechanisms leading to AF [28] and VT [29] by performing various in silico experiments. Our objective is to develop personalized anatomical and biophysical models in order to improve the planning and guidance of RFA therapies on patients suffering from AF and VT. Indeed, those patient-specific models can evaluate the impact of some RFA lines on the induction of AF and VT. By testing several ablation strategies, we plan to estimate their potential efficacy and thus provide additional guidance to the cardiologists. One important difficulty in this approach is to cope with the chaotic nature of AF and VT while biophysical models lead to deterministic results. A way to tackle this issue is to perform several simulations with varying biophysical parameters in order to estimate probabilities of inducing AF and VT.
For the personalization of those models, we use patient-specific data such as invasive intracardiac electrical recordings obtained at the time of RFA for AF and during electrophysiological studies for VT. Multi-channel ECG recording (64þ leads), so-called body surface potential mapping (BSPM), is also considered in this research as a non-invasive pre-operative electrophysiology imaging technique [ECG imaging, electrocardiographic imaging (ECGI)]. This technique can complement intracardiac mappings but requires solving an inverse problem in order to estimate action potential data on the epicardium of the patient's heart. Furthermore, near-simultaneous MRI imaging provides cardiac geometry, tissue characteristics (gadolinium late-enhancement MRI for highlighting scars in the myocardium in VT patients and ablation patterns in AF patients) and heart motion (for VT).
Towards this goal, a realistic model of the anatomy and electrophysiology of the atria has been developed in order to simulate AF. First, we are using a volumetric voxel representation of the atria with a rule-based, spatially varying thickness of the atrium wall. Furthermore, the anisotropy effects owing to specialized atrial structures (Bachmann's bundle, crista terminalis and pectinate muscles) are taken into account. A semi-automatic procedure [30] has been devised to create patient-specific computational meshes of the atria, including some fibre orientation from patient's MR images [31] . Additionally, we are evaluating the influence of other interatrial conduction pathways on the development of atrial flutter and tachycardias. The electrophysiology propagation is based on the Courtemanche -Ramirez -Nattel cell model [32] and adjusted to parameters provided in the literature. It also incorporates electrical remodelling owing to AF. Cell coupling is achieved by the monodomain formulation in a Cþþ framework [33] . The model shows good correspondence to measured action potentials of chronic AF patients. We are also working on the effect of haemodialysis (HD) on the atrial action potential and the increased prevalence for AF owing to HD [34] . Just as with the model for chronic AF, we aim to achieve with its consideration a personalization of the model to specific groups of patients.
Current work in progress includes the electrophysiological modelling of the atria after RFA by combining the joint effect of scar, ablated tissue and oedema. In particular, this study includes testing how the initiation of AF is affected by the addition of ablation lines. Longterm RFA success rates are moderate overall, perhaps owing to regenerating myocardium. Figure 4 shows an example of the impact of ablated tissue on excitation propagation during sinus rhythm in a patient-specific model. Damaged tissue from RFA was identified by late-enhancement MRI shortly after the procedure. Two pulmonary veins were not isolated during the procedure. The patient was re-admitted a few months after the intervention as AF recurred. Personalized electrophysiological models may be used to understand long-term RFA effects and thus increase success rates in the future.
For the simulation of post-infarcted VT, we are modelling the VT-stimulation (VT-stim) protocol used in clinics to induce VT. VT-stim is a clinical protocol that consists of a number of extrastimuli introduced at two ventricular sites [right ventricle (RV) apex and RV outflow tract], using various cycle lengths, with varying coupling intervals [35] . Induction of VT in this stimulation protocol may be due to both slow conduction and longer effective refractory period in the peri-infarct regions compared with healthy regions. The clinical VT-stim protocol has been simulated on a three-dimensional biventricular mesh built from patient images using a reduced electrophysiological model [36] discretized on a tetrahedral mesh with linear FEs. As reported by other research groups working on the induction of VT [29] , it is important to account for the specificity of the pathological areas including the scars and peri-infarct zones in terms of boundary conditions. The anatomy and scar locations have been acquired and extracted from SSFP and late-enhancement MR images recorded at KCL. The cardiac fibre orientations are derived from an atlas generated from ex vivo canine hearts [37] . The peri-infarct region within scars corresponding to the isthmus plays a crucial role in VT induction. Indeed, the personalization of the electrophysiological model parameters from intracardiac non-contact mappings [38] leads to decreased conductivities in the isthmus compared with surrounding healthy tissues. Similarly, the personalized action potential duration (APD) restitution curves lead to longer APD in the isthmus compared with healthy tissue. In figure 3 , VT-stim is simulated by pacing at RV-apex with 600 ms pacing cycle length and two extrastimuli with the shortest coupling interval of 100 ms. Stimulus S1 has a normal propagation in the isthmus; however, stimulus S2 faces a unidirectional block at the isthmus, which was created by APD heterogeneity and slow conduction of the previous S1 wave in the isthmus. This block creates a re-entry of the wave from the opposite direction, which is sustained and has a constant frequency. Thus, the induced reentry is called as sustained monomorphic VT. More details about this work can be found in Relan et al. [38] . Current limitations of this work include the uncertainty in the image segmentation of scars and peri-infarct zones as well as their characterization in terms of electrophysiological properties. Furthermore, the non-deterministic nature of VT should be assessed as well as the difference of VT-stim predictions between in silico experiments and electrical mappings measured on the patient. A protocol for the acquisition of ECGI at St Thomas' Hospital has been established based on an 80-channel vest of electrodes coupled with whole-heart and thorax MRIs. This has led to the acquisition of four datasets on healthy volunteers and patients with paroxysmal AF. Endocardial data acquisition is available for one of those patients as a way to evaluate the accuracy of activation time reconstruction. The analysis of those datasets requires performing several image-and signal-processing steps [31, 39] . These include the wholeheart MRI segmentation for the endocardium of the ventricles and atria and epicardium of the left ventricles (LVs). The epicardial walls of the left and right atria and right ventricle are manually segmented. Another tedious task includes the manual segmentation of several inner organs from MRI. Finally, the continuous ECGI data are converted into an averaged and filtered template ECGI signal and interpolated onto the segmented MRI thorax (figure 5).
Based on the segmented dataset and taking into account the non-homogeneous electrical conductivities of the thorax, the propagation of the extracellular potential from the atria to the body surface has been simulated. First, a comparison between the measured BSPM and the simulated potential has been performed [31] . In particular, we have performed a thorough sensitivity analysis of the effect of conduction velocity, initial stimulation points and mesh size on the simulated P-wave signal. Second, the inverse problem of electrocardiography has been addressed, i.e. estimating the times of activation on the atria given the measured BSPM. For calibration purposes, simulated BSPM corrupted with noise has been tested as an input of the inverse mapping and activation times on the atria have been estimated using Tikhonov regularization [40] . Along with the generalized minimal residual method, Tikhonov regularization is used by the leading groups in the field [41] . Additional a priori knowledge on the activation patterns has been used to further constrain the solution, including several new methods that are based on assumed action potential curves and the effects of local depolarizations on the BSPM. Our future work will focus on improving the stability of the methods and on a comprehensive approach to reduce the effects and sources of modelling errors.
LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION AND CONGENITAL TRANSPOSITION
Building on the electromechanical work outlined above provides the opportunity to include the addition of fluid mechanics in the cardiac modelling frameworks and address the loss of myocardial contractility in HF.
The resultant reduction in the ability of the heart to pump blood in this disease currently accounts for a significant reduction in both mortality and morbidity in Western society. Despite this significance, the aetiology of the disease remains poorly understood, is complex and context-specific, spanning age groups and conditions. In young adults who have undergone surgery to correct congenital transposition (where the two main arteries leaving the heart are reversed at birth), the initially successful switch of the ventricles often ultimately results in the systemic ventricle, now on the right of the heart, failing. Such developments bring into focus the appropriateness of the initial surgical intervention and how subject groups are assessed and selected for procedures. In elderly populations, HF is rapidly becoming an epidemic, a fact confounded by the severe lack of donor hearts, with transplant as the only established long-term solution. To create a bridge to transplant, LVADs are often surgically inserted by reducing load by pumping blood from the bottom of the LV directly into the aorta. In a recent and highly promising development, a small but significant (approx. 5%) subpopulation with implanted LVADs (Berlin Heart, Steglitz, Germany) has completely recovered, undergoing cardiac remodelling to the point where the LVAD can be removed. The mechanisms underlying such remodelling remain conjecture; however, if the underlying mechanisms were properly understood, customizing LVAD function via patient-specific tuning to both investigate how LVAD placement and flow rate could be optimized to benefit cardiac function and promote remodelling now has the potential to provide a huge clinical gain.
While the treatment developments outlined above are encouraging, solutions that identify the interventions to produce individual benefits in congenital and LVAD patients require input from multiple disciplines. Using multi-modal data, our goal is to exploit the potential of multi-scale computational frameworks to interpret unique clinical imaging to optimize clinical protocols and direct device design and tuning work. This research is motivated by the clinical outcomes of developing tools to specifically (i) redefine the criteria for patient selection to define the most appropriate target group for surgical intervention, (ii) tune the performance of an LVAD to optimize the haemodynamic benefits to a specific individual, and (iii) identify the common ventricular flow-myocardial wall mechanic features that promote remodelling of the ventricle and recovery from HF. Our approach is to refine our existing modelling framework to develop an integrated computational model of cardiac contraction coupled to ventricular fluid dynamics [42] . Full nonlinear passive and active constitutive relations are combined with the finite deformation governing equations using the FE method. Using the coupling approach for general fluid solid modelling previously developed by Nordsletten et al. [43] [44] [45] , the biophysics governing the myocardial deformation (solid mechanics) has been coupled to fluid mechanics within the ventricular chamber. The resulting equations have been solved by an FE-based arbitrary Lagrange Eulerian (ALE) approach. The endo-and epicardial meshes were fitted to the data using a nonlinear fitting process, performed using the CMISS software package. 7 The volume meshes were constructed by linear interpolation between the corresponding nodes on the endo-and epicardial surfaces. To ensure smoothness of flow, inflow and outflow cannulae were constructed at the mitral and aortic valve planes. The LVAD cannula geometry was provided by the device manufacturer (Berlin Heart, Steglitz, Germany). The fluid mesh, within the LV, was constructed using Cubit 8 and the fluid -solid interface elements were defined as a separate domain. Simulations are run on these fitted geometries in order to capture the effect LVADs have on ventricular function and blood recirculation within the LV cavity. Results from one of these simulations are shown in figure 6 , where mean inflow velocity was prescribed so that filling was isovolumetric over one cardiac cycle and inflow and outflow velocities fitted from comprehensive MR measurements. Boundary conditions for the mechanics problem were included to fix both the mitral valve plane and the apex, where the LVAD cannula was attached.
These simulations reveal the complex dynamics that occur around the LVAD cannula, which in turn result in recirculation at the apex, below the LVAD mouth. Also of note is the absence of a primary vortex typical of normal ventricular filling owing to the presence of the LVAD cannula. Furthermore, the action of the LVAD cannula close to the myocardial wall has the potential to induce suction effects on the endocardium, producing a significant impact of cardiac pump function. Balancing the impact of an LVAD on ventricular flow with this negative impact of suction presents an optimization problem whereby pump function, currently set at a constant velocity in axial flow LVADs, could be tuned to optimize the mechanics of the cardiac cycle. Current work is focused on validation of the model using comprehensive data-acquired preimplantation and CT imaging after the pump has been implanted. From this validated framework, the model will be applied to explore the functional envelope induced by different LVAD flow profiles as part of the focus of our ongoing work.
In young adults, we focus on hypo-plastic left heart, which is a condition that affects four to five children out of 10 000 births and poses a serious threat to life, requiring immediate surgical treatment in the majority of the cases. Hypo-plastic left heart patients can rely solely on the right ventricle as a motor for the systemic and the pulmonary circulation, the left one being atrophied or underdeveloped. To assist the surgeon in planning the intervention, we use biophysical simulations to assess diastolic dysfunction through the analysis of pressure gradients and myocardial relaxation (figure 7). In the rapid filling phase (early diastole), the annular velocity during the ventricle elongation, e 0 , is recorded as well as the velocity of the inflow at the inlet valve, E. Previous studies in the literature have demonstrated that the ratio E/e 0 is an important clinical parameter to predict the filling pressures and to highlight diastolic abnormalities. The flow propagation and vortex formation mechanism is analysed in the hypo-plastic left heart cases and compared with the previous results obtained from patients affected by congenitally corrected transposition of the great arteries. Our goal in this work is to use the information provided by the model to underpin a clinical trial at the end of the project to test the value of computational metrics for selecting patients who will respond to surgical treatment.
CORONARY PERFUSION
CAD is the major cause of mortality worldwide, despite the fact that currently available strategies to lower individual risk factors and treat evident coronary artery stenoses have reduced cardiovascular event rates by 20-30%. In addition, a definite exclusion of epicardial coronary artery stenosis is mainly achieved by invasive angiography. Owing to the high risk of the disease and the difficulty in excluding it, a large number of patients undergo invasive stenosis treatment with negative results. Therefore, developing improved modalities for the diagnosis and treatment of coronary disease is important for both increased quality of life and reduction of the cost associated with CAD. The ability to assess in a personalized manner epicardial CAD as well as disturbed blood flow control and increased microvascular resistance earlier and with higher accuracy will allow us to improve prevention and reduce health costs. Assessing alterations of coronary or microvascular flow is also important in patients with other cardiac abnormalities including aortic stenoses and HF, which are disease foci discussed elsewhere in this paper.
In the past, the focus has been on the improvement of measurement of characteristic dimensions of coronary stenosis in order to predict its clinical significance. However, this clinical significance is determined by the limiting effect a stenosis has on the myocardial perfusion increase needed for exercise levels above basal daily activity. Specifically, coronary flow reserve [46] is defined as the ratio between maximal reachable coronary flow and maximal obtainable flow at exercise and hence requires the measurement of flow under two conditions, while one may argue that only the limitations on maximal obtainable perfusion are relevant. Based on a number of assumptions, the reduction in maximal flow can be derived from the relative pressure drop over a coronary stenosis during pharmacological-induced maximal vasodilation, which is denoted as fractional flow reserve [47, 48] . It has become clear that these physiological indices are doing better in predicting the need for stenosis treatment than angiography alone [6, 49] . However, different indices may result in different treatment suggestions, indicating that a more precise analysis of coronary ( patho) physiology is needed [50] , which has become possible by the introduction of a guide wire measuring distal pressure and flow velocity simultaneously [51] .
Earlier physiological studies have clearly demonstrated that the inner layer of the heart muscle, the subendocardium, is more vulnerable to ischaemia than the outer layers of the heart [52] . Only recently techniques have become available to measure the distribution of blood perfusion over the heart muscle clinically [53] . In particular, MRI-based methods are promising because of their practical clinical application and high resolution [54] . MRI basically measures arrival and passage of a contrast agent through the tissue. However, interpretation of these image-based methods requires more detailed understanding of transport of blood through the microcirculation.
In the past, several efforts have been made to model coronary flow distribution [55] [56] [57] based on assumed branching rules of coronary arteries, which are based on certain space-filling criteria or branching rules derived from coronary corrosion casts [58] . Our goal is to deliver a multi-scale, multi-physics model to allow a much more sensitive and precise sensing of perfusion abnormalities of cardiac tissue not only in the epicardial arteries but also in the mircocirculation. The approach is to develop such a model based on the real measured anatomy of the coronary vascular bed down to the micron diameter level, its interrelationship with heart muscle fibre orientation and the biophysical processes responsible for the compression of intramural vessels, especially in the subendocardium [7, 59, 60] . Similar approaches have been proposed before and indeed have contributed substantially to our present insights. In the absence of information, three-dimensional vascular branching models have been constructed [55, 56] based on stochastic branching rules derived from corrosion casts of pig coronary vasculature [58] . Simplified distribution models indicate that the interaction between layers at different myocardial depths depends on epicardial stenosis resistance [61] . The fibre orientation has been precisely measured in small hearts and successively applied to the large heart models [62] . The innovation of the model constructed within the euHeart project is within the application of realistic three-dimensional information on vascular branching and fibre sheet information as obtained by a novel imaging cryomicrotome [63] integrated into personalized mechanical models of heart contraction [26] . In this model, perfusion in the microcirculation is implemented using FE-based porous elastic techniques to couple perfusion (modelled using Darcy flow) to contracting tissue (modelled via large deformation mechanics). Pressure boundary conditions are applied to the endocardium along with no-flux flow conditions at the endo-and epicardial surfaces. Apart from its clinical use in diagnosis support, the resulting model provides potential to analyse a wider variety of biophysical processes relevant at different levels in the coronary circulation as recently reviewed [62, 64] . On the myocardial wall, yellow represents low and red high deformation, and black lines are contour bands. Note the uniaxial flow from the inlet valve to the outflow cannula and the absence of a primary vortex. Vortices form either side of the peak velocity jet, travelling apex to base, which cause outward deformation of the wall normal to the jet path. Also note the suction effects on the LV wall close to the cannula mouth. Recirculations are not apparent at the apex below the cannula mouth.
euHeart: Personalized cardiac modelling N. Smith et al. 357 In the past 2 years, the focus has been on improving technologies for obtaining and interpreting images [65, 66] . Based on the point spread function, the images are filtered, followed by segmentation of the vascular structure, which now will allow for computation of flow distribution over the vascular tree into the different compartments of the myocardium. These models will have to be validated by clinical image-based perfusion studies as well as animal studies [67] for which microsphere distribution provides a gold standard ( figure 8 ). The imaging of the intramural vasculature in post-mortem human hearts will be used to increase our insights into specific vascular abnormalities such as end-stage HF [68] .
From the clinical side, studies are under way to compare MRI perfusion measurements with epicardial artery-derived indices for inducible ischaemia. Specifically, wave intensity analysis (WIA) has been introduced for coronary arterial flow analysis [69] . WIA combines the time derivatives of coronary pressure and velocity signals. As flow velocity and pressure pulsatilities are generated by compression of the microcirculation, WIA allows us to derive parameters describing microvascular function and in future work will be used to validate the model under development [70 -72] .
The challenge in applying the model analysis to clinical data is the integration of perfusion distribution data by MRI and selective haemodynamic measurements in epicardial arteries by smart guide wires used for catheterization. Mechanistically, these phenomena are related since the contraction of the heart is responsible for perfusion distribution by impeding microvascular flow at the local level and the pulsatile nature of coronary flow and pressure in the epicardial arteries. However, it is not clear yet whether the sensitivities of the interactions are similar at similar level of coronary disease. It is conceivable that the epicardial haemodynamic alterations are early signs of vascular disease while perfusion disturbances only occur after some Figure 7 . The vortex formation in the systemic right ventricle of a patient with hypo-plastic left heart. The ring vortex is formed during the peak E wave in proximity of the aortic valve, as shown in figure 1a . During the deceleration period, it expands and travels axially away from the formation region (figure 1b). At diastasis (figure 1c), the maximum volume expansion is attained on a circumferential plane located just below the valve orifices and the two vortices merge into one complex swirling structure. No additional vortex pair is observed during the atrial contraction (figure 1d), unlike in the normal LV filling, where a weak ring vortex appears near to the mitral inlet. larger progression of disease. For these distinctions, clinical validation of the model under development is needed.
AORTIC COARCTATION
Aortic coarctation is a constriction in the aorta, usually located just after the branching of the arteries that supply the head and arms. It is one of the most common congenital heart defects, affecting one in 10 000 individuals. A significant proportion (10-20%), treated in the neonatal period, develop re-coarctation [73] .
The fundamental problem associated with aortic coarctation is that it increases the after-load on the heart, reducing flow for a given amount of work and increasing cardiac and arterial pressures proximal to the coarctation, including in the vessels that supply the head [74] . This increase in after-load leads to increased risk of CAD and stroke.
In principle, aortic coarctation is a physics problem that is a perfect subject for study using the techniques of computational fluid dynamics. The easiest coarctations to detect are those that feature a significant geometrical narrowing of the vessel, visible in diagnostic images. Such coarctations produce a pressure elevation that is, at least as a first approximation, computable from the Bernoulli equation, although the fact that the flow is pulsatile, combined with often complex anatomy, might indicate a requirement for more sophisticated computational fluid dynamics (CFD) computations using three-dimensional models constructed from the medical images. More subtle coarctations might present little, or even no, significant narrowing but are characterized by an increased local stiffness of the vessel. The aorta is essentially an elastic tube, the physics of which can be approximated by a one-dimensional model, and a local stiffness change causes wave reflections that again lead to elevated cardiac and proximal vessel pressures. A brief review of computational methods applied to aortic coarctation is presented by Ladisa et al. [75] .
In clinical practice, pressure drops are measured invasively using a pressure catheter, usually under a protocol that includes a pull-back through the region of the stenosis. A complicating factor is that there are large numbers of patients with mild coarctation or recoarctation who have little pressure gradient at rest, but hypertension particularly on exercise. Often, but not always, this condition can be simulated pharmacologically and pressure drops can again be measured invasively. Our first target of the analysis of aortic coarctation is to explore in what percentage of case the pressure drop might be predicted reliably from the description of the geometry alone (i.e. without any information on local or global stiffnesses). This includes the extrapolation from the rest to the stress condition. There is strong clinical interest in the identification, without invasive measurements, of those coarctations that will become physiologically significant under exercise.
euHeart has built a processing chain and a workflow, suitable for operation in a clinical environment, that take a medical image of the aorta, together currently with measured transient flows and pressures as inputs and computes the pressure drop across the coarctation. Flow is computed by the integration of through-plane MRI velocity measurements on a cross section in the ascending aorta and in cross sections in the branching vessels at the top of the arch, and applied to the model as a boundary condition at these locations. Invasive pressure catheter measurements are applied at the distal end of the model, in the descending aorta. The CFD solution is computed in ANSYS CFX, a commercial code that uses an element-based finite-volume method with second-order discretization in space and time. Refinements to the workflow include the use of zerodimensional models to compute boundary conditions, possibly tuned to individual patient measurements. A range of solver options is possible, from the simplest rigid-walled analysis through to full-system fluid-solid interaction solutions of the type described by Kim et al. [76] .
Preliminary results have been produced for a series of five cases, each under boundary conditions representative of rest and pharmacological stress conditions, using a transient, rigid-walled analysis, with the pressure drop computed at the instant of peak flow. Figure 8a ,b illustrate the computed distribution of pressure in the aorta (spatial distribution on the inner surface of the artery at peak flow and temporal distribution along the centreline, respectively) for one coarctation case. Figure 9c illustrates the simulation of a pressure catheter pullback, overlaid on the clinical data for this operation. Although the Bernoulli pressure well in the throat of the coarctation is deeper in the simulation than in the clinical measurement, the pressure drop across the coarctation is well represented even with this simple analysis model.
In all cases, as would be expected, the simulation (using measured flow boundary conditions) predicted an increase in the pressure drop under stress relative to that under the rest condition. In four of the five cases, the analysis provided a prediction of the pressure drop under rest conditions that was within the range of clinical measurements (with an error of 3 mmHg or less) and certainly of sufficient accuracy for diagnostic purposes. As a check, additional analyses were performed on subjects with normal aortas and, again as expected, the pressure drops were very low (of the order of 1 mmHg). The extrapolation to the stress condition proved less reliable, with errors of the order of 30 per cent relative to the measured pressure drop, but nevertheless in four of the cases, the analysis correctly predicted that physiologically significant pressure gradients (greater than 40 mmHg) were present. Although improvements of the processing chain are underway, the results already indicate that clinically meaningful computations of the physiological severity of the coarctation should be possible. The most serious simplification in the analysis method for which results are presented in this section is the assumption of rigid walls of the aorta, which means that capacitive and wave transmission effects are not captured, but further flow boundary conditions on the smaller branching vessels at the top of the arch is a further restriction, and indeed a likely source of error and inconsistency, and there is a strong case for the adoption of tuned Windkessel models as an alternative.
DISCUSSION AND CONCLUSIONS
In this article, we have aimed to summarize the ongoing work within the euHeart project to develop and apply patient-specific models within a number of specific contexts. Given the wide context of this work, these summaries are necessarily brief and the interested reader is referred to the detailed literature in each of the specific areas. However, a number of general conclusions can be drawn.
While the development of multi-scale, multi-physics models, such as the cardiac frameworks demonstrated above, continues to progress, the clinical diagnosis and treatment of CVD still largely depends on complex mental integration based on specific clinical experience and phenomenological-derived indexes. In addition to improved patient selection and therapy optimization, the application of these models also allows the concept of 'intelligent' imaging to be introduced. Specifically, this requires a transition towards quantified metrics that are mechanistically linked to cardiac function to enable two interrelated issues to be addressed; specifically (i) how can imaging protocols be optimized in specific clinical contexts to improve diagnosis and treatment planning and (ii) what is the information content that can be extracted from the clinical data which will most effectively inform clinical practice. The integration of state-of-the-art imaging modalities, functional measurements and cardiac models now provides exactly the required foundation from which to progress this goal further.
The types of numerical methods that are used in the euHeart programme (FEs, finite differences, etc.) have long been employed in other industries, including aerospace and automotive applications. It is recognized that there is a strong need for benchmarks against which codes can be validated. These are developed and promoted by agencies like the National Agency for Finite Element Methods and Standards in the UK. The computations performed in euHeart cover a broad spectrum of physics (reaction-diffusion, electromechanical and fluid mechanics) over a wide range of complexity (up to state-of-the-art fully coupled multi-physics simulations). In order to achieve credibility, it is important that our simulation tools and workflows are validated. Recently, the FDA has published [77] a CFD benchmark to challenge the community to produce accurate simulations of the flow in a very simple geometry but under challenging Reynold's numbers. Some of our partners have experience in organizing cross-institutional challenges in the cardiovascular domain to the stimulate benchmarking and best practices across groups [78] . The long-term goal is to demonstrate to the FDA whether simulation can provide a credible method of assessment of devices like LVADs. Such developments would have a potential impact on a much quicker identification of good-performance devices, discarding inadequate device concepts or designs, and the concomitant safety and savings in time and cost associated with early identification of unsuccessful devices. euHeart has recognized the importance of carefully validated benchmarks as a community resource against which the performance of numerical codes can be evaluated, and has made a series of test problems and results publicly available through its euHeartDB database [9] . Already this has proved valuable in comparing results from wider community members, outside the euHeart programme, including the identification of discrepancies that have led to code improvements. The euHeart project focuses on the translational aspects of multi-scale cardiovascular modelling into clinical environments and the demonstration of potential clinical benefits on patient outcome. Several workflows are being developed jointly between scientists and clinicians. One of the most advanced of them is the one focused on CRT presented above, covering the whole chain from access to clinical data and their processing, patient-specific modelling, simulation and treatment planning. For this reason, one multi-centre pilot trial, including approximately multi-modal data for 120 patients acquired in three clinical centres in three different countries (UK, France and Spain), will be performed. The main goal of this pilot trial is to demonstrate the clinical benefit in determining the optimal lead placement and pacing sequence in CRT by prospectively analysing with the developed tools the patient database. The pilot trial is currently in the phase of data acquisition and preliminary testing of the developed imaging and modelling algorithms on these patient-specific data, as shown in figures 4 and 10. The image and model processing of the whole database of patients remains a challenge that will be faced during the second part of the project. The clear definition of the different workflows as well as the integration of the different tools into a common software platform will hopefully help on this issue. Finally, it must be pointed out that this pilot trial is a first initiative towards a large-scale clinical trial including modelling tools, but further joint discussions between clinicians and technicians are still needed to effectively embed these advanced tools into typical clinical trials.
The longer term outcome of the euHeart programme will be a consistent, biophysically based framework for quantitative data integration, interpretation of information and knowledge extraction using the developed computational imaging and modelling tools. Our hope and expectation is that this in turn will support a paradigm shift away from clinical indices determining treatment options based on population-based patient selection or risk profiles and a move towards true personalization of care based on the interpretation of the patient data and history in the context of his/her specific physiology. Our goal and expectation for this work, perhaps echoed across the VPH community, is that through this project we will be able to collectively make a significant positive impact on the treatment and prevention of heart disease. euHeart: Personalized cardiac modelling N. Smith et al. 361
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